AKT1 and hepatocellular carcinoma: Subsequently, DYRK1 in the cytoplasm activates Akt/GSK‐3β signaling, enhancing the stability and nuclear localization of cyclin D1, thereby accelerating cell cycle progression and facilitating the malignant proliferation of HCC.20